Evolus (EOLS) Cash from Financing Activities (2017 - 2026)

Evolus (EOLS) reported Cash from Financing Activities of $7.6 million for Q1 2026, up 567.14% on a YoY basis from $1.1 million in Q1 2025, and up 9794.81% quarter-over-quarter from $77000.0 in Q4 2025.

Evolus (EOLS) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Evolus has reported Cash from Financing Activities for 10 years, with the latest figure at $7.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 567.14% year-over-year to $7.6 million; the trailing twelve-month figure through Mar 2026 stood at $26.6 million (up 21872.73% YoY), and the FY2025 full-year result was $17.3 million, down 63.43% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $7.6 million, up from $77000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $45.7 million in Q1 2024, with the low at -$1.8 million in Q3 2025.
  • Historically, Cash from Financing Activities has averaged $6.6 million across 5 years, with a median of -$849000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities plunged 109.3% — and 2024, when it surged 3661.78%.
  • Evolus' Cash from Financing Activities stood at -$1.5 million in 2022, then surged by 1651.58% to $23.5 million in 2023, then sank by 105.58% to -$1.3 million in 2024, then surged by 105.86% to $77000.0 in 2025, then soared by 9794.81% to $7.6 million in 2026.
  • The last three Cash from Financing Activities figures came in at $7.6 million (Q1 2026), $77000.0 (Q4 2025), and -$1.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Evolus 437.40 Mn 387.61 Mn 48.90 Mn 7.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.62 Mn
Mar 31, 2026 7.62 Mn
Dec 31, 2025 77,000.00
Dec 31, 2025 77,000.00
Sep 30, 2025 -1.77 Mn
Sep 30, 2025 -1.77 Mn
Jun 30, 2025 20.66 Mn
Jun 30, 2025 20.66 Mn
Mar 31, 2025 -1.63 Mn
Mar 31, 2025 -1.63 Mn
Dec 31, 2024 -1.31 Mn
Dec 31, 2024 -1.31 Mn
Sep 30, 2024 -1.42 Mn
Sep 30, 2024 -1.42 Mn
Jun 30, 2024 4.48 Mn
Jun 30, 2024 4.48 Mn
Mar 31, 2024 45.66 Mn
Mar 31, 2024 45.66 Mn
Dec 31, 2023 23.52 Mn
Dec 31, 2023 23.52 Mn